Chongqing Sansheng Building Materials Co Ltd (002742)

Chongqing Sansheng Industrial Co.,Ltd. develops, produces and sells building materials and chemicals in China and internationally. It operates through two segments, Buildings Materials Chemical Industry; and Pharmaceutical Manufacturing. The company offers commercial concrete, water reducing agents, and expansion agents for industrial and civil buildings, highways, railways, bridges, tunnels, airports, water conservancy, and hydropower; sulfuric acid for the production of fertilizers, chemicals, light industry, textile, steel, water reducer, and other non-fertilizer acid enterprises; and concrete admixtures. It also provides pharmaceutical products comprising intermediates, such as procaine hydrochloride, cefoxitin acid intermediates, chlorine intermediates, chloramphenicol intermediates, aztreonam intermediates, and orlistat intermediates for use as antibiotic drugs, anti-hepatitis C drugs, diabetes drugs, benzathine penicillin and cefoxitin, procaine penicillin, and cosmetics; and API products, including acetaminophen, cloperidine hydrochloride, levofloxacin mesylate, benolate, and diphenhydramine hydrochloride. In addition, the company offers preparation products, such as compound paracetamol diphenhydramine, cloperidine hydrochloride, clarithromycin sustained-release, diclofenac sodium enteric-coated, acetaminophen, and famotidine tablets, which are used for antipyretic and analgesic, anti-inflammatory viruses, antibacterial, cough, allergy, and local anesthesia, as well as famotidine, diclofenac sodium, nifedipine, sodium nitrate, acetaminophen, furosemide, and norfloxacin drugs. Further, it provides solid preparation, large infusion, and small volume parenteral pharmaceutical products. The company was formerly known as Chongqing Sansheng Special Building Materials Co., Ltd. and changed its name to Chongqing Sansheng Industrial Co.,Ltd. in October 2016. Chongqing Sansheng Industrial Co.,Ltd. was incorporated in 2002 and is headquartered in Chongqing, China.